Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism

Linking Metabolic Reprogramming, Plasticity and Tumor Progression

(2021) Oleg Shuvalov et al.   Cancers

Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma

(2020) Zoe Hall et al.   HEPATOLOGY

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma

(2020) Moris Sangineto et al.   Cancers

Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression

(2020) Ji Hye Yang et al.   Life Science Alliance

Insights into the success and failure of systemic therapy for hepatocellular carcinoma

(2019) Jordi Bruix et al.   Nature Reviews Gastroenterology & Hepatology

Downregulation of Epidermal Growth Factor Receptor in hepatocellular carcinoma facilitates Transforming Growth Factor-β-induced epithelial to amoeboid transition

(2019) Judit López-Luque et al.   CANCER LETTERS

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer

(2019) Wan Hua et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma

(2019) Li Che et al.   Frontiers in Oncology

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids

(2018) Nadia Senni et al.   GUT

Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States

(2018) Dongya Jia et al.   Cells

Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis

(2018) Isabel Fabregat et al.   Frontiers in Oncology

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma

(2018) Hayato Nakagawa et al.   Cancers

Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer

(2017) Marco Sciacovelli et al.   FEBS Journal

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors

(2017) Andrea Morandi et al.   Frontiers in Oncology

Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism

(2017) Jitka Soukupova et al.   Scientific Reports

TGF-β signalling and liver disease

(2016) Isabel Fabregat et al.   FEBS Journal

Role of epithelial to mesenchymal transition in hepatocellular carcinoma

(2016) Gianluigi Giannelli et al.   JOURNAL OF HEPATOLOGY

Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells

(2016) Dan Cao et al.   LIVER INTERNATIONAL

Cancer metabolism: a therapeutic perspective

(2016) Ubaldo E. Martinez-Outschoorn et al.   Nature Reviews Clinical Oncology

A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy

(2015) Ruth Sánchez-Martínez et al.   Oncotarget

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

(2015) Aritro Nath et al.   Scientific Reports

Neuronal Progenitor Maintenance Requires Lactate Metabolism and PEPCK-M-Directed Cataplerosis

(2014) Zaida Álvarez et al.   CEREBRAL CORTEX

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

(2014) Valerie S. LeBleu et al.   NATURE CELL BIOLOGY

Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition

(2014) L Jiang et al.   ONCOGENE

Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells

(2013) Esther Bertran et al.   HEPATOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL